The EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe are funded by the European Foundation for the Study of Diabetes (EFSD) together with Novo Nordisk. The programme supports diabetes research in Europe and Associated Countries and accept applications from all fields of diabetes research including both basic and clinical research. Applicants must be members of the EASD. Funds of 100,000 EUR are available for 1 year or longer. Applications close on February 1, 2023.